Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Long-term Potentiation01:35

Long-term Potentiation

55.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
55.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Dementia01:30

Dementia

113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
113

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reporting and data systems for laparoscopic cholecystectomy with findings of a user adoption survey.

Scientific reports·2026
Same author

EEG-induced Effective Connectivity Analysis in Major Depressive Disorder.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Exploring Creativity Through the Eyes: A New Framework Using Rorschach Inkblot Test Metrics.

Annals of neurosciences·2025
Same author

Exploring Self-Supervised Models for Depressive Disorder Detection: A Study on Speech Corpora.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Artificial Intelligence Based Hierarchical Classification of Frontotemporal Dementia.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

A Regression Framework for Predicting Cognitive Decline in Frontotemporal Dementia using Recurrent Neural Networks.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

相关实验视频

Updated: Jun 28, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

预测阿尔茨海默病的进展使用一个多功能序列-长度-自适应编码器-解码器LSTM架构.

Km Poonam, Rajlakshmi Guha, Partha P Chakrabarti

    IEEE journal of biomedical and health informatics
    |April 9, 2024
    PubMed
    概括
    此摘要是机器生成的。

    这项研究引入了一种适应性深度学习模型,用于预测阿尔茨海默病 (AD) 的进展. 序列长度自适应编码器-解码器长短期记忆模型通过更多的患者数据提高了准确性,有助于早期干预.

    更多相关视频

    Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
    06:52

    Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

    Published on: July 6, 2019

    9.3K
    Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
    06:46

    Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

    Published on: August 4, 2018

    12.2K

    相关实验视频

    Last Updated: Jun 28, 2025

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.0K
    Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
    06:52

    Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

    Published on: July 6, 2019

    9.3K
    Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
    06:46

    Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

    Published on: August 4, 2018

    12.2K

    科学领域:

    • 神经学 神经学
    • 人工智能的人工智能
    • 医疗信息学 医疗信息学

    背景情况:

    • 早期和准确的阿尔茨海默病 (AD) 检测对于有效的治疗和管理至关重要.
    • 在单个时间点使用现有的诊断分数和临床状态来预测疾病进展仍然具有挑战性.
    • 目前用于AD检测的深度学习模型往往缺乏稳定性,因为对纵向数据的适应训练不足.

    研究的目的:

    • 开发一种自适应的深度学习模型,在六年内预测个体阿尔茨海默病诊断状态.
    • 通过整合纵向患者数据来提高预测性能,每次额外的患者访问都会得到改善.
    • 在现实临床环境中解决非适应性深度学习模型的局限性.

    主要方法:

    • 开发一个序列长度自适应编码器-解码器长短期存储器 (SLA-ED LSTM) 模型.
    • 使用来自阿尔茨海默病神经成像计划 (ADNI) 档案的纵向数据.
    • 动态调整解码器LSTM以适应可变的训练和推理序列长度.

    主要成果:

    • 该SLA-ED LSTM模型显示了高的预测准确性.
    • 对于一个推断长度为1,一个连续长度为9次访问的序列长度产生了最高的平均测试准确度 (0.920) 和AUC (0.982).
    • 该模型在预测疾病进展方面显著超过了最先进的方法.

    结论:

    • 大约9次患者访问的纵向数据足以捕捉有意义的认知变化,以准确预测AD进展.
    • 拟议的SLA-ED LSTM模型为早期阿尔茨海默病检测和进展预测提供了稳定和改进的方法.
    • 这种适应性深度学习策略有望提高阿尔茨海默病管理中的临床决策.